Lumito Arrow right Arrow right

The future is here

With Lumito’s unique and patented technology, there are provisions to significantly improve the diagnostics for tissue samples through shorter analytical times and higher quality analysis. Lumito’s technology also provides completely new opportunities to search for multiple disease indications in the same tissue section, multiplexing. Our technique offers digital analysis and automation.



Lumito AB Quarterly Report (1 Jan to 31 March) 2021

Show press release
Financial reports


Quarterly report 3, 2020, Lumito AB (publ)

Show report


Mattias Lundin presented the company at Aktiedagen, please see the full presentation here. ►

Read more


Watch the latest presentations from Lumito.

Read more

Get the latest news directly in your inbox

Subscribe here